within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A06A_DrugsForConstipation.A06AH01_MethylnaltrexoneBromide;

model MethylnaltrexoneBromide
  extends Pharmacolibrary.Drugs.ATC.A.A06AH01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>MethylnaltrexoneBromide</td></tr><tr><td>ATC code:</td><td>A06AH01</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Methylnaltrexone bromide is a peripherally-acting μ-opioid receptor antagonist (PAMORA) used to treat opioid-induced constipation in adult patients with chronic non-cancer pain or advanced illness. It is approved for clinical use and marketed under several names, including Relistor.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after a single subcutaneous injection.</p><h4>References</h4><ol><li><p>Rotshteyn, Y, et al., &amp; Yuan, CS (2011). Methylnaltrexone bromide: research update of pharmacokinetics following parenteral administration. <i>Expert opinion on drug metabolism &amp; toxicology</i> 7(2) 227–235. DOI:<a href=\"https://doi.org/10.1517/17425255.2011.549824\">10.1517/17425255.2011.549824</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21222554/\">https://pubmed.ncbi.nlm.nih.gov/21222554</a></p></li><li><p>Mozaffari, S, et al., &amp; Abdollahi, M (2018). Methylnaltrexone bromide for the treatment of opioid-induced constipation. <i>Expert opinion on pharmacotherapy</i> 19(10) 1127–1135. DOI:<a href=\"https://doi.org/10.1080/14656566.2018.1491549\">10.1080/14656566.2018.1491549</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29979903/\">https://pubmed.ncbi.nlm.nih.gov/29979903</a></p></li><li><p>Zhang, D, et al., &amp; Liu, H (2018). Pharmacokinetic study of methylnaltrexone after single and multiple subcutaneous administrations in healthy Chinese subjects. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 48(8) 804–808. DOI:<a href=\"https://doi.org/10.1080/00498254.2017.1364449\">10.1080/00498254.2017.1364449</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28776489/\">https://pubmed.ncbi.nlm.nih.gov/28776489</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end MethylnaltrexoneBromide;
